Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy

Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy

Abstract Background Our aim was to assess the heterogeneity of high-risk (HR) prostate cancer managed with high-dose external beam radiotherapy (EBRT) with androgen deprivation therapy (ADT). Methods We identified 547 patients who were treated with modern EBRT from 1997 to 2013, of whom 98% received...

Full description

Bibliographic Details
Main Authors: Daniel N. Cagney, Mary Dunne, Carmel O’Shea, Marie Finn, Emma Noone, Martina Sheehan, Lesley McDonagh, Lydia O’Sullivan, Pierre Thirion, John Armstrong
Format: Article
Language:English
Published: BMC 2017-08-01
Series:BMC Urology
Online Access:http://link.springer.com/article/10.1186/s12894-017-0250-2

Internet

http://link.springer.com/article/10.1186/s12894-017-0250-2

Similar Items